Sleep Apnea, Obstructive Terminated Phase 2 Trials for MK-0249 (DB11910)

IndicationStatusPhase
DBCOND0030275 (Sleep Apnea, Obstructive)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00620659Treatment of Refractory Excessive Daytime Sleepiness in Patients With Obstructive Sleep Apnea/Hypopnea Syndrome (OSA/HS) Using Nasal Continuous Positive Airway Pressure (nCPAP) Therapy (0249-015)Treatment